Negotiations around Amedisys Inc.’s (NASDAQ: AMED) Contessa subsidiary were a significant contributor to the pendulum swing that led to the company’s acquisition by UnitedHealth Group’s (NYSE: UNH) Optum rather than Option Care Health (NASDAQ: OPCH). Optum in June penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]
Thus far in 2023, hospice merger and acquisition activity has deviated from prior years. This year is distinctive because of factors such as valuations, asset sizes and the mix of buyers. A number of trends have shifted. The last five years saw record-breaking multiples in the hospice space and private equity-backed platform deals were among […]
Enhabit Inc. (NYSE: EHAB) has announced plans to launch a strategic review process that could result in a potential sale. The consideration marks another move among large home health and hospice providers in the industry. The company is getting ready to explore various transaction options in order to satisfy the terms of its Tax Matters […]
UnitedHealth Group (NYSE: UNH) has been relatively quiet on its strategic plans with Amedisys (NASDAQ: AMED), which it is in the process of acquiring via its subsidiary, Optum. The company shed some light on how the home health and hospice asset will fit into its overall scope of services Friday, however. Optum announced plans to […]
The UnitedHealth Group (NYSE: UNH) subsidiary Optum has penned a deal to acquire Amedisys (NASDAQ: AMED) in an all-cash transaction of $101 per share, or about $3.3 billion. The pending transaction followings a previous offer to aquire Amedisys by the home infusion company Option Care Health (NASDAQ: OPCH) for $3.6 billion. “We are excited about […]
Recent allegations that staff at HCA Healthcare (NYSE: HCA) put pressure on patients to enter hospice dovetail with longstanding questions over how and when patients should be referred. A recent report from the Service Employees International Union (SEIU) alleges that HCA has pressured clinicians to inappropriately “push” patients and families to accept hospice referrals. The […]
A minority investor in Enhabit Inc. (NYSE: EHAB) is urging the hospice and home health provider to consider a “full and fair sale process.” The investor – New York-based hedge fund AREX Capital Management, which holds about 4.5% of the shares of Enhabit – brought up the sale idea in a letter sent to the […]
As the demand for palliative care continues to grow, so too has the way businesses have bolstered their programs to better serve patients. Providers are consistently looking for new methods to deliver responsive, value-based services that can generate savings and reduce high-acuity utilization. Hospice News spoke with three palliative care providers that have risen to […]
In 2022, the hospice community laid the groundwork for a transformational 2023. This year saw industry-changing acquisitions, some of the worst labor headwinds to date, the return of sequestration and a sometimes volatile national economy. During late 2021 and 2022, the U.S. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice […]
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
